Volpara acquires breast cancer risk assessor for $23.6m
WELLINGTON: Breast cancer detection technology company Volpara has made its largest acquisition to ... read more
CBA bankrolls Crescent Clinical Labs attempted float
SYDNEY: Commonwealth Bank of Australia has spearheaded a refinancing for the country’s third-largest ... read more
Hopper’s CAR-T start-up is an early hit
MELBOURNE: CAR-T cancer therapy company Chimeric Therapeutics is set for a cracking start ... read more
